Epilepsy is a neurological disorder that can affect individuals of all ages, including children. Managing epilepsy in young patients requires specialized care and expertise, and this is where a pediatric …
The Role of a Pediatric Neurologist in Managing Childhood Epilepsy Read More »
Dr. Jeffrey Gelblum, Senior Neurologist at First Choice Neurology educates patients about the risk of dementia and Alzheimer’s disease. Dr. Gelblum offers bi-weekly Lunch and Learn talks on Facebook LIVE …
Dr. Jeffrey Gelblum Talks about Proton Pump Inhibitors and Your Risk of Dementia Read More »
New Alzheimer’s drugs may benefit whites more than black Americans, leading Alzheimer’s experts told Reuters. Leqembi and donanemab are the first Alzheimer’s drugs to offer real hope of slowing cognitive …
New Alzheimer’s Drugs May Benefit Whites More Than Blacks Read More »
June is an important month for raising awareness about Alzheimer’s disease and promoting brain health. This year, Alzheimer’s & Brain Awareness Month brings exceptional news for those affected by this …
June is an important month for millions of individuals who suffer from migraines and headaches. It is designated as Migraine and Headache Awareness Month, a time dedicated to raising awareness …
Migraine and Headache Awareness Month: Understanding and Support Read More »
According to a study led by researchers at UCLA, the Alzheimer’s drug Leqembi would raise future costs for Medicare by $2 billion to $5 billion a year. Leqembi, sold for …
Study finds Alzheimer’s drug Leqembi would cost Medicare up to $5 billion a year Read More »
May is ALS awareness month. Each May, our community comes together to raise awareness of the disease, share stories from people living with ALS, show our support for caregivers, families, …
First Choice Neurology will be an exhibitor at the 2023 American Academy of Neurology (AAN) Annual Meeting. The AAN Annual Meeting is the largest meeting of neurologists and neuroscience professionals …
First Choice Neurology Exhibiting at the AAN Annual Meeting Read More »
The MIND diet was developed in 2015 by Rush University nutritional epidemiologist Martha Clare Morris and her colleagues. The MIND diet is a scientifically proven eating plan that aims to …
MIND Diet Helps to Prevent Dementia and Alzheimer’s Disease Read More »
The FDA approved the new Alzheimer’s drug lecanemab (BAN2401), which will be sold under the brand name Leqembi developed by Eisai and Biogen last week for patients with mild cognitive …
